Vivoryon Therapeutics

Vivoryon Therapeutics (VVY) will release its Q3 2025 financial results and operational progress on December 4, 2025. A conference call and webcast will be held at 3:00 pm CET / 9:00 am EST. The webcast will be available on Vivoryon’s investor relations site. Participants planning to dial in are encouraged to pre-register for expedited access and to call in 15 minutes early. The company will provide an update on its varoglutamstat program for diabetic kidney disease.